Yes, we are working closely with existing registries that monitor the long term safety of treatments for psoriasis to support the timely and detailed reporting of cases of COVID-19. We are also working together with case reporting registries  of COVID-19 in other important inflammatory conditions such as eczema and arthritis. We hope that this will help us to better understand how COVID-19 affects people with different  diseases and help doctors make decisions about treatments.